We utilized induced pluripotent stem cells (iPSCs) derived from a hereditary pulmonary hypertension (PH) patient carrying a pathogenic BMPR2 mutation (c.631C>T, p.Arg211Trp). This evidence concerns the gene BMPR2 and pulmonary hypertension.